182 related articles for article (PubMed ID: 28218345)
1. Risk of Non-melanoma Skin Cancer in Patients with Atopic Dermatitis Treated with Oral Immunosuppressive Drugs.
Garritsen FM; van der Schaft J; van den Reek JM; Politiek K; van Os-Medendorp H; van Dijk M; Hijnen DJ; de Graaf M; Bruijnzeel-Koomen CA; de Jong EM; Schuttelaar MA; Bruin-Weller MS
Acta Derm Venereol; 2017 Jun; 97(6):724-730. PubMed ID: 28218345
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
[TBL] [Abstract][Full Text] [Related]
3. Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern.
Keller B; Braathen LR; Marti HP; Hunger RE
Swiss Med Wkly; 2010; 140():w13036. PubMed ID: 20652847
[TBL] [Abstract][Full Text] [Related]
4. Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis.
Asgari MM; Tsai AL; Avalos L; Sokil M; Quesenberry CP
JAMA Dermatol; 2020 Oct; 156(10):1066-1073. PubMed ID: 32785626
[TBL] [Abstract][Full Text] [Related]
5. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and clinical evolution of non-melanoma skin cancer in renal transplant recipients: a single-center experience in São Paulo, Brazil.
Hayashida MZ; Fernandes VM; Fernandes DR; Ogawa MM; Tomimori J
Int J Dermatol; 2015 Oct; 54(10):e383-8. PubMed ID: 25969871
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for non-melanoma skin cancer in kidney transplant patients in a Spanish population in the Mediterranean region.
Bernat García J; Morales Suárez-Varela M; Vilata JJ; Marquina A; Pallardó L; Crespo J
Acta Derm Venereol; 2013 Jul; 93(4):422-7. PubMed ID: 23303600
[TBL] [Abstract][Full Text] [Related]
8. Subsequent nonmelanoma skin cancers and impact of immunosuppression in liver transplant recipients.
Funk-Debleds P; Ducroux E; Guillaud O; Ursic-Bedoya J; Decullier E; Vallin M; Euvrard S; Pageaux GP; Boillot O; Dumortier J
J Am Acad Dermatol; 2018 Jul; 79(1):84-91. PubMed ID: 29307647
[TBL] [Abstract][Full Text] [Related]
9. Management of non-melanoma skin cancer in solid organ transplant recipients.
Specchio F; Saraceno R; Chimenti S; Nistico S
Int J Immunopathol Pharmacol; 2014; 27(1):21-4. PubMed ID: 24674675
[TBL] [Abstract][Full Text] [Related]
10. Epithelial skin cancers after kidney transplantation: a retrospective single-centre study of 376 recipients.
Kaufmann RA; Oberholzer PA; Cazzaniga S; Hunger RE
Eur J Dermatol; 2016 Jun; 26(3):265-70. PubMed ID: 26985913
[TBL] [Abstract][Full Text] [Related]
11. Non-melanoma skin cancers and glucocorticoid therapy.
Karagas MR; Cushing GL; Greenberg ER; Mott LA; Spencer SK; Nierenberg DW
Br J Cancer; 2001 Sep; 85(5):683-6. PubMed ID: 11531252
[TBL] [Abstract][Full Text] [Related]
12. Overview on non-melanoma skin cancers in solid organ transplant recipients.
Forchetti G; Suppa M; Del Marmol V
G Ital Dermatol Venereol; 2014 Aug; 149(4):383-7. PubMed ID: 25068224
[TBL] [Abstract][Full Text] [Related]
13. Risk of Non-Melanoma Skin Cancer in Connective Tissue Disease and The Impact of Immunosuppressive Therapy.
Gunawardane ND; Dontsi M; Lyon LL
J Drugs Dermatol; 2020 May; 19(5):519-523. PubMed ID: 32484614
[TBL] [Abstract][Full Text] [Related]
14. Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors.
Chakravarty EF; Michaud K; Wolfe F
J Rheumatol; 2005 Nov; 32(11):2130-5. PubMed ID: 16265690
[TBL] [Abstract][Full Text] [Related]
15. Incidence of Malignancies in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Diagnosed Between 1991 and 2013.
Rahmattulla C; Berden AE; Wakker SC; Reinders ME; Hagen EC; Wolterbeek R; Bruijn JA; Bajema IM
Arthritis Rheumatol; 2015 Dec; 67(12):3270-8. PubMed ID: 26246307
[TBL] [Abstract][Full Text] [Related]
16. Atopic dermatitis and risk of skin cancer: a Danish nationwide cohort study (1977-2006).
Jensen AO; Svaerke C; Körmendiné Farkas D; Olesen AB; Kragballe K; Sørensen HT
Am J Clin Dermatol; 2012 Feb; 13(1):29-36. PubMed ID: 22175302
[TBL] [Abstract][Full Text] [Related]
17. Non-melanoma skin cancer in patients with atopic dermatitis treated with topical tacrolimus.
Naylor M; Elmets C; Jaracz E; Rico JM
J Dermatolog Treat; 2005 Aug; 16(3):149-53. PubMed ID: 16096180
[TBL] [Abstract][Full Text] [Related]
18. Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis.
Ariyaratnam J; Subramanian V
Am J Gastroenterol; 2014 Feb; 109(2):163-9. PubMed ID: 24419479
[TBL] [Abstract][Full Text] [Related]
19. Expression of p53 up-regulated modulator of apoptosis (PUMA) in non-melanoma skin cancer of long-term immunosuppressed solid organ transplant recipients compared to immunocompetent patients.
Neuberger A; Menzer C; Volk N; Enk AH; Hadaschik EN; Lonsdorf AS
Eur J Dermatol; 2021 Oct; 31(5):609-615. PubMed ID: 34903507
[TBL] [Abstract][Full Text] [Related]
20. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
